SCHEMBL2180407

SCHEMBL2180407

CCCCCc1ccc(C(=O)Nc2ccc(-c3ccc4c(c3)C(=O)N([C@H](C(=O)O)C(C)C)C4)c(Cl)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.42
ITGA2B P08514 2/20 0.42
ITGA2 P17301 2/20 0.42
TRPV1 Q8NER1 5/20 0.39
PLK1 P53350 2/20 0.39
SDCBP O00560 1/20 0.38
SDC2 P34741 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 3/20 0.38
CFTR P13569 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PRSS12 P56730 1/20 0.37
PPARA Q07869 1/20 0.36
MAPK14 Q16539 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2180410 1.00 ITGB3 (0.42) ITGB3ITGA2BITGA2TRPV1PLK1
SCHEMBL2181140 0.92 RARB (0.44) ITGB3ITGA2BITGA2TRPV1PLK1
SCHEMBL2176949 0.92 RARB (0.44) ITGB3ITGA2BITGA2TRPV1PLK1
SCHEMBL2176983 0.91 RARB (0.45) ITGB3ITGA2BITGA2TRPV1PLK1
SCHEMBL2180430 0.91 RARB (0.45) ITGB3ITGA2BITGA2TRPV1PLK1
SCHEMBL2179566 0.90 TRPV1 (0.44) ITGB3ITGA2BITGA2TRPV1SDCBP
SCHEMBL2179559 0.90 TRPV1 (0.44) ITGB3ITGA2BITGA2TRPV1SDCBP
SCHEMBL2178463 0.90 GAA (0.44) ITGB3ITGA2BITGA2TRPV1PLK1
SCHEMBL2178458 0.90 GAA (0.44) ITGB3ITGA2BITGA2TRPV1PLK1
SCHEMBL2180558 0.90 TRPV1 (0.44) ITGB3ITGA2BITGA2TRPV1PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748426-B2 Inhibitors of diacylglycerol acyl transferase Piramal Enterprises Limited (IN) 2014-06-10 US claimed
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Enterprises Limited (IN) 2012-11-15 US claimed
EP-2519500-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Healthcare Ltd. (IN) 2012-11-07 EP claimed
WO-2011080718-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-07-07 WO claimed
US-8748426-B2 Inhibitors of diacylglycerol acyl transferase Piramal Enterprises Limited (IN) 2014-06-10 US disclosed
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Enterprises Limited (IN) 2012-11-15 US disclosed
EP-2519500-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Healthcare Ltd. (IN) 2012-11-07 EP disclosed
WO-2011080718-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE DGAT1, DGAT2, LCAT ITGB3 4621/4885ITGA2B 4607/4885ITGA2 4531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.